GENEVA, Jan. 27 -- CYTOMX THERAPEUTICS, INC. (151 Oyster Point Blvd., Suite 400South San Francisco, California 94080) filed a patent application (PCT/US2025/038373) for "ACTIVATABLE IL-12 CONSTRUCTS AND RELATED COMPOSITIONS AND METHODS" on Jul 18, 2025. With publication no. WO/2026/020161, the details related to the patent application was published on Jan 22, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): CAI, Na (c/o CytomX Therapeutics, Inc.151 Oyster Point Blvd., Suite 400South San Francisco, California 94080), LE SCOLAN, Erwan (c/o CytomX Therapeutics, Inc.151 Oyster Point Blvd., Suite ...